SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-20-001878
Filing Date
2020-03-27
Accepted
2020-03-27 16:26:40
Documents
100
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2241137z10-k.htm 10-K 1519598
2 EX-4.22 a2241137zex-4_22.htm EX-4.22 9756
3 EX-21.1 a2241137zex-21_1.htm EX-21.1 3261
4 EX-23.1 a2241137zex-23_1.htm EX-23.1 7472
5 EX-31.1 a2241137zex-31_1.htm EX-31.1 8198
6 EX-31.2 a2241137zex-31_2.htm EX-31.2 7996
7 EX-32.1 a2241137zex-32_1.htm EX-32.1 4576
8 EX-32.2 a2241137zex-32_2.htm EX-32.2 4524
15 G299172.JPG g299172.jpg GRAPHIC 130304
  Complete submission text file 0001047469-20-001878.txt   9060003

Data Files

Seq Description Document Type Size
9 EX-101.INS ontx-20191231.xml EX-101.INS 2009388
10 EX-101.SCH ontx-20191231.xsd EX-101.SCH 79953
11 EX-101.CAL ontx-20191231_cal.xml EX-101.CAL 57336
12 EX-101.DEF ontx-20191231_def.xml EX-101.DEF 256323
13 EX-101.LAB ontx-20191231_lab.xml EX-101.LAB 640770
14 EX-101.PRE ontx-20191231_pre.xml EX-101.PRE 489158
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36020 | Film No.: 20752148
SIC: 2834 Pharmaceutical Preparations